Tag: Myriad Genetics Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Myriad Genetics Inc.

$155.19 Million in Sales Expected for Myriad Genetics, Inc. (NASDAQ:MYGN) This Quarter

Added to Collection on: 2021-05-04 05:26:15

Tags for this article:

Finance
Money
Economy
Financial ratios
Financial markets
Corporate finance
Stock
Stock market
Myriad Genetics
Rate of return
Price?earnings ratio
Charles Schwab Corporation
Zacks
Myriad Genetics Inc.

Click the tags to see associated articles and topics

View Article Details
Partner Fund Management, LP Buys Neurocrine Biosciences Inc, Myriad Genetics Inc, Baxter ...

Added to Collection on: 2021-05-18 21:38:58

Tags for this article:

Finance
Financial markets
Financial economics
Corporate finance
Stock
Stock market
Subprime mortgage crisis
The Gores Group
BioMarin Pharmaceutical Inc.
Anthem Inc.
Neurocrine Biosciences Inc.
Syndax Pharmaceuticals Inc
Bristol-Myers Squibb Company
Jounce Therapeutics Inc
Irhythm Technologies Inc
Baxter International Inc.
Henry Schein Inc.
Myriad Genetics Inc.

Click the tags to see associated articles and topics

View Article Details
Myriad Genetics Appoints Melissa Gonzales to Lead Women's Health Business

Added to Collection on: 2021-05-20 11:03:45

Tags for this article:

Branches of biology
Medical genetics
Biology
Medicine
Medical tests
Biotechnology
Myriad Genetics
Genetic testing
Molecular diagnostics
Precision medicine
United States
Myriad Genetics Inc.

Click the tags to see associated articles and topics

View Article Details
Myriad Genetics CEO Paul J. Diaz to Present at Goldman Sachs 2021 Virtual Global Healthcare ...

Added to Collection on: 2021-06-04 11:03:45

Tags for this article:

Medical genetics
Branches of biology
Medicine
Clinical medicine
Myriad Genetics
Genetic testing
Myriad Genetics Inc.

Click the tags to see associated articles and topics

View Article Details
After Sinking -5.11% During Past Week, Is Myriad Genetics, Inc. (NASDAQ:MYGN) Still A Buy?

Added to Collection on: 2021-06-05 16:02:03

Tags for this article:

Financial markets
Finance
Money
Stock market
Share trading
Day trading
Stock
Short
IShares
Myriad Genetics
NASDAQ
Overweight
Myriad Genetics Inc.

Click the tags to see associated articles and topics

View Article Details
Thomas P. Slavin, MD, Named Chief Medical Officer for Myriad Genetics

Added to Collection on: 2021-06-16 20:03:45

Tags for this article:

Branches of biology
Medical genetics
Medicine
Biology
Medical tests
Biotechnology
Myriad Genetics
Genetic testing
Molecular diagnostics
Precision medicine
American College of Medical Genetics and Genomics
Personalized medicine
Myriad Genetics Inc.

Click the tags to see associated articles and topics

View Article Details
Brokerages Expect Myriad Genetics, Inc. (NASDAQ:MYGN) Will Post Earnings of -$0.07 Per Share

Added to Collection on: 2021-07-19 07:07:30

Tags for this article:

Finance
Money
Economy
Financial ratios
Corporate finance
Stock market
Valuation
Fundamental analysis
Price?earnings ratio
Myriad Genetics
Earnings per share
Financial analyst
Myriad Genetics Company
Myriad Genetics Inc.

Click the tags to see associated articles and topics

View Article Details
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 ...

Added to Collection on: 2021-08-05 12:00:00

Tags for this article:

Finance
Pharmaceutical companies
Economy of New York City
NASDAQ
Financial markets
Alnylam Pharmaceuticals
Dow Jones Industrial Average
Arbutus Biopharma
NASDAQ-100
Nasdaq, Inc.
Maravai LifeSciences Holdings, Inc.
AbSci CORP
Novo Nordisk A/S
Alkermes Plc
Innoviva Inc
Sanofi
Cytek Biosciences Inc.
Horizon Therapeutics Public Limited Company
Eli Lilly and Company
DexCom Inc.
Bio-Rad Laboratories Inc.
Laboratory Corporation of America Holdings
Myriad Genetics Inc.
Translate Bio Inc
Protagonist Therapeutics Inc
ResMed Inc.
Edwards Lifesciences Corporation
BeyondSpring Inc.
Monte Rosa Therapeutics Inc.
Nuvalent Inc.
REPLIGEN CORPORATION
Alnylam Pharmaceuticals Inc.
BioNTech SE
Johnson & Johnson
Bristol-Myers Squibb Company
Zoetis Inc.
Genmab A/S
Moderna, Inc.
Impel NeuroPharma Inc.
Quest Diagnostics Incorporated
Immuneering Corporation
Intuitive Surgical Inc

Click the tags to see associated articles and topics

View Article Details
Jerry S. Lanchbury Sells 28225 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN) Stock

Added to Collection on: 2021-08-07 23:14:23

Tags for this article:

Financial markets
Finance
Financial economics
Stock market
Corporate finance
Equity securities
Financial ratios
Shareholders
Myriad Genetics
Stock
Price?earnings ratio
Short
Myriad Genetics Company
Myriad Genetics Inc.

Click the tags to see associated articles and topics

View Article Details
Liquid Biopsy Market Giants To Grow At Much Faster Pace | GRAIL, ANGLE, Menarini ...

Added to Collection on: 2021-12-23 07:57:50

Tags for this article:

Medicine
Clinical medicine
Medical specialties
DNA
Biopsy
Anatomical pathology
Oncology
Interventional radiology
Liquid biopsy
Circulating free DNA
Circulating tumor DNA
Pathology
silicon biosystems
Clearbridge BioMedics Pte Ltd
Genomic Health
Pathway Genomics
Qiagen NV
Menarini
Exosome Diagnostics Inc
Roche Diagnostics
RainDance Technologies
Biocept Inc.
TrovaGene Inc.
Thermo Fisher Scientific Inc.
cynvenio biosystems, inc.
MDxHealth
ANGLE plc
F. Hoffmann-La Roche AG
Personal Genome Diagnostics
FOUNDATION MEDICINE , INC
Bio-Rad Laboratories Inc.
Myriad Genetics Inc.

Click the tags to see associated articles and topics

View Article Details